Low dose thalidomide maintenance in myeloma patients after autologous stem cell transplantation

被引：0
|
作者：
Bayer, R. -L. [1 ]
John, V. [1 ]
Devoe, C. [1 ]
Cannon, M. [1 ]
Klocke, J. [1 ]
Gissinger, D. [1 ]
机构：
[1] N Shore Univ Hosp, Manhasset, NY USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2007年 / 13卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2006.12.146
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
142
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [21] Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial
    Rosinol, L.
    Oriol, A.
    Teruel, A. I.
    de la Guia, A. L.
    Blanchard, Ma J.
    de la Rubia, J.
    Granell, M.
    Sampol, Ma A.
    Palomera, L.
    Gonzalez, Y.
    Etxebeste, Ma A.
    Martinez-Martinez, R.
    Hernandez, M. T.
    de Arriba, F.
    Alegre, A.
    Cibeira, Ma T.
    Mateos, Ma V.
    Martinez-Lopez, J.
    Lahuerta, J. J.
    Miguel, J. San
    Blade, J.
    LEUKEMIA, 2017, 31 (09) : 1922 - 1927
  • [22] Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients
    Patriarca, F
    Sperotto, A
    Prosdocimo, S
    Geromin, A
    Zaja, F
    Fanin, R
    HAEMATOLOGICA, 2003, 88 (05) : 597 - 599
  • [23] Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients
    Patriarca, F
    Sperotto, A
    Prosdocimo, S
    Geromin, A
    Zaja, F
    Fili, C
    Cerno, M
    Fanin, R
    BONE MARROW TRANSPLANTATION, 2003, 31 : S78 - S79
  • [24] Low dose thalidomide as maintenance in multiple myeloma
    ElSorady, M.
    ElGhandour, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 355 - 355
  • [25] Treatment of myeloma patients relapsed after frontline autologous stem cell transplantation with the association of thalidomide, dexamethasone and zoledronate.
    Musto, P
    Bodenizza, C
    Falcone, A
    Sanpaolo, G
    Cascavilla, N
    Melillo, L
    Dell'Olio, M
    La Sala, A
    Mantuano, S
    Nobile, M
    Scalzulli, PR
    Greco, MM
    Carella, AM
    Beltrami, G
    Carella, AM
    BLOOD, 2003, 102 (11) : 382B - 382B
  • [26] Low dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma.
    Kroeger, N
    Shimoni, A
    Zagrivnaja, M
    Ayuk, F
    Lioznov, M
    Schieder, H
    Fehse, B
    Zabelina, T
    Nagler, A
    Zander, A
    BLOOD, 2004, 104 (11) : 457A - 458A
  • [27] Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma
    Kröger, N
    Shimoni, A
    Zagrivnaja, M
    Ayuk, F
    Lioznov, M
    Schieder, H
    Renges, H
    Fehse, B
    Zabelina, T
    Nagler, A
    Zander, AR
    BLOOD, 2004, 104 (10) : 3361 - 3363
  • [28] Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma
    Kröger, N
    Shimoni, A
    Zagrivnaja, M
    Ayuk, F
    Lioznov, M
    Schieder, H
    Renges, H
    Fehse, B
    Zabelina, T
    Nagler, A
    Zander, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S47 - S47
  • [29] Low dose thalidomide as maintenance in multiple myeloma
    El Sorady, M.
    Elghandour, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 481 - 481
  • [30] Maintenance therapy after Autologous Stem Cell Transplantation in Multiple Myeloma - currents and perspectives
    Zylka, Krzysztof
    Gil, Lidia
    Dytfeld, Dominik
    JOURNAL OF MEDICAL SCIENCE, 2024, 93 (02):
12345